2.63
+0.29(+12.39%)
Currency In USD
| Previous Close | 2.34 |
| Open | 2.42 |
| Day High | 2.62 |
| Day Low | 2.4 |
| 52-Week High | 70.14 |
| 52-Week Low | 2.02 |
| Volume | 89,065 |
| Average Volume | 185,988 |
| Market Cap | 2.28M |
| PE | -0.01 |
| EPS | -250.62 |
| Moving Average 50 Days | 3 |
| Moving Average 200 Days | 19.86 |
| Change | 0.19 |
If you invested $1000 in Nuwellis, Inc. (NUWE) 10 years ago, it would be worth $0 as of December 04, 2025 at a share price of $2.525. Whereas If you bought $1000 worth of Nuwellis, Inc. (NUWE) shares 5 years ago, it would be worth $0 as of December 04, 2025 at a share price of $2.525.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.
GlobeNewswire Inc.
8 hours ago
Pediatric nephrology and cardiology teams continue to seek out Aquadex for safe, precise fluid management in complex casesMINNEAPOLIS, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delive
Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology
GlobeNewswire Inc.
Nov 10, 2025 2:00 PM GMT
Continues momentum in pediatric innovation and platform developmentMINNEAPOLIS, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal condition
Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025
GlobeNewswire Inc.
Oct 23, 2025 1:00 PM GMT
MINNEAPOLIS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, addressing the critical interplay between the heart and kidneys,